, , , , , , , , , , ,
doi.org/10.2215/CJN.07610520, hdl.handle.net/1765/128750
Clinical Journal of the American Society of Nephrology
Department of Internal Medicine

Zietse, R. (2020). ADPKD, tolvaptan, and nephrolithiasis risk. Clinical Journal of the American Society of Nephrology, 15(7), 923–925. doi:10.2215/CJN.07610520